How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Building a model capable of RSI would require automating a range of specialist tasks currently carried out by humans. At ...

Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Recursive Superintelligence, founded by former Google, Meta and OpenAI researchers, is part of a growing effort to automate the creation of artificial intelligence. By Cade Metz Reporting from San ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

May 22, 2026 Scientists have uncovered a strange hidden structure formed during the creation of metallocenes, a class of sandwich-like molecules used in everything from catalysis to medicine. The ...

Join the NHL and its corporate partners at the FREE official tailgate of the 2025 Navy Federal Credit Union NHL Stadium Series. Saturday, March 1, 2025 from 12:00 PM - 5:00 PM ET No Ticket Required!

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Arthur Gies Arthur Gies is an editor for Wirecutter's tech coverage. He's ...

John Edwards is a licensed attorney with experience in commodities and investments. He provides performance analysis of hedge funds and investors. An LLC offers flexibility in management and tax ...